Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4855686
Max Phase: Preclinical
Molecular Formula: C92H138N8O20
Molecular Weight: 1676.15
Molecule Type: Unknown
Associated Items:
ID: ALA4855686
Max Phase: Preclinical
Molecular Formula: C92H138N8O20
Molecular Weight: 1676.15
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCCCCCCCCC(=O)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43)NCCCCCCCCCCC(=O)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43
Standard InChI: InChI=1S/C92H138N8O20/c101-81(93-29-15-11-7-3-1-5-9-13-17-83(103)95-69-19-21-75-73(59-69)91-27-31-97-65-67-23-35-119-77-63-85(105)99(75)89(91)87(77)71(67)61-79(91)97)25-33-107-37-39-109-41-43-111-45-47-113-49-51-115-53-55-117-57-58-118-56-54-116-52-50-114-48-46-112-44-42-110-40-38-108-34-26-82(102)94-30-16-12-8-4-2-6-10-14-18-84(104)96-70-20-22-76-74(60-70)92-28-32-98-66-68-24-36-120-78-64-86(106)100(76)90(92)88(78)72(68)62-80(92)98/h19-24,59-60,71-72,77-80,87-90H,1-18,25-58,61-66H2,(H,93,101)(H,94,102)(H,95,103)(H,96,104)/t71-,72-,77-,78-,79-,80-,87-,88-,89-,90-,91+,92+/m0/s1
Standard InChI Key: KBMXWRQHIYJAPJ-SBTVUUJFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1676.15 | Molecular Weight (Monoisotopic): 1675.0027 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Zlotos DP, Abdelmalek CM, Botros LS, Banoub MM, Mandour YM, Breitinger U, El Nady A, Breitinger HG, Sotriffer C, Villmann C, Jensen AA, Holzgrabe U.. (2021) C-2-Linked Dimeric Strychnine Analogues as Bivalent Ligands Targeting Glycine Receptors., 84 (2.0): [PMID:33596384] [10.1021/acs.jnatprod.0c01030] |
Source(1):